Home Online Features Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
Hand-out
Press Releases
Biocon Biologics Ltd.  
March 6, 2025

Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States

BRIDGEWATER, N.J. and PETERSBURG, Va. and BENGALURU, India, March 6, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code:

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social